|LETTER TO EDITOR
|Year : 2017 | Volume
| Issue : 2 | Page : 93
European Chapter of International Society of Digital Medicine and Clinerion
Le Vin Chin
Head of Marketing and Communications, Clinerion, Switzerland
|Date of Web Publication||18-Sep-2017|
Le Vin Chin
Clinerion, Margarethenstrasse 47, 4053 Basel
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Chin LV. European Chapter of International Society of Digital Medicine and Clinerion. Digit Med 2017;3:93
We salute the establishment of the European Chapter of the International Society of Digital Medicine and its publication, the Digital Medicine Journal.
The digitalization of medicine is going to have huge impacts on the cost efficiency of drug development, drug delivery, and patient health in the decades to come. One clear case we can see is the creation huge time and cost savings during the clinical trials of new drugs in development. Today, the recruitment of patients for these trials is a lengthy and inefficient process, taking months and often failing when not enough patients are found., However, imagine if you could find eligible candidates instantaneously by querying digital patient records! This time saving would allow next generation medicines to be evaluated and authorized much quicker, getting them to doctors and patients much earlier.
Operating as we do in the area of big data analytics methodologies to support patient recruitment, market access, and real-world evidence, we can also see very clearly that a consistent and concerted vision is needed for continued success. The case outlined above works best if all healthcare providers have a similarly high level and high quality of digital patient data and if they are all accessible by the same query engine. This vision can only come from a rigorous, but respectful, scientific exchange, and a constructive dialog, all of which are fostering of innovation. We have high hopes therefore for the platform offered by Digital Medicine Journal and look forward to contributing strongly and often and engaging with other contributors.
We wish Digital Medicine Journal and the International Society of Digital Medicine every success, going forward!
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Beresniak A, Schmidt A, Proeve J, Bolanos E, Patel N, Ammour N, et al.
Cost-benefit assessment of using electronic health records data for clinical research versus current practices: Contribution of the Electronic Health Records for Clinical Research (EHR4CR) European Project. Contemp Clin Trials 2016;46:85-91.
Tufts Center for the Study of Drug Development: 89% of Trials Meet Enrollment, but Timelines Slip, Half of Sites Under-Enroll, Impact Report. Vol. 15; January/February, 2013.